• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    More On ACL.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Alchemia Limited (ACL.AX)

    -ASX
    0.01 0.00(0.00%) 12:10AM EST
    ProfileGet Profile for:
    Alchemia Limited
    3 Hi
    Eight Mile Plains
    Brisbane, QLD 4113
    Australia - Map
    Phone: 61 7 3340 0200
    Fax: 61 7 3340 0222
    Website: http://www.alchemia.com.au

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:N/A

    Business Summary 

    Alchemia Limited, a biotechnology company, engages in developing human therapeutic products based on its proprietary drug discovery and synthesis technologies in Australia and the United States. The company operates through Fondaparinux and HyACT segments. It provides generic Fondaparinux, an injectable anticoagulant drug for the prevention and treatment of deep vein thrombosis and pulmonary embolism. The company also offers HyACT, a platform technology that uses the non-toxic and naturally occurring carbohydrate, hyaluronic acid as a drug delivery vehicle for a range of approved anti-cancer therapeutics. In addition, it is developing HA-Irinotecan that is in the Phase II clinical trials for the treatment of small cell lung cancer. The company has collaboration agreement with Merck Serono to develop HA-Irinotecan in combination with therapeutic antibody, Erbitux (cetuximab), for patients with metastatic colorectal cancer. Alchemia Limited was founded in 1995 and is headquartered in Brisbane, Australia.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Alchemia Limited

    Key Executives 
     PayExercised
    Dr. Tracey Jean Brown B.Sc., Ph.D., 53
    Chief Scientific Officer, VP of Oncology and Member of Clinical Advisory Board
    N/AN/A
    Mr. Stephen Denaro BCom, CA, MAICD, GradDipAppliedCorpGovernance,
    Company Sec.
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.